FebuxostatFEBUMORE 80 MG TABLET

New beginning in the management of hyperuricemia and gouty attacks with Febumore, the oral non-purine selective xanthine oxidase inhibitor. Xanthine oxidase is needed to oxidize the metabolites of purine, ultimately to uric acid, thereby increasing the serum concentration of it. Febumore 80 mg offers faster and greater serum urate reduction compared to Febumore 40 mg and older molecules.

• Dosage: Once Daily OR as directed by the physician
• Form: Tablet
• Indications:
  1. Gout flares and Tophus
  2. Hyperuricemia in patients with Gout
  3. Renal and Hepatic impairment with Hyperuricemia
• Composition: Febuxostat 80 mg
• Mode of Action:Purine- and pyrimidine-rich foods (e.g. meat, fish, spinach) are metabolized by xanthine oxidase (XO), leading to uric acid production and hyperuricemia. Febuxostat (Febumore) is a potent, selective XO inhibitor that lowers serum urate more effectively than older molecules, without affecting other metabolic enzymes. At a starting dose of 40 mg, Febumore shows significant urate reduction within 2 weeks, with no dose adjustment needed in mild-to-moderate renal or hepatic impairment. For faster and sustained urate control, Febuxostat 80 mg achieves higher target serum urate reduction and better long-term symptom management in gout and hyperuricemic patients.
• Packaging:10*10’s
• Therapy Area: Anti-hyperuricemic